Resonant Medical develops, manufactures and commercializes 3D ultrasound image-guided adaptive radiotherapy products. Our goal is to help cancer centers make significant improvements in radiation therapy planning, verification and delivery – to advance patient care. We design high-performance products based on next-generation technologies that exceed the technical and clinical requirements of our customers while respecting the realities of operating cancer centers.
Geared for innovation
A privately-held company founded in 2000 by industry experts, Resonant is driven by 45 innovative employees with world-class expertise and experience. Our R&D group benefits from a unique mix of leading-edge clinical and computational expertise in radiotherapy, medical physics, ultrasound physics, sonography, image analysis and applied mathematics, while our Engineering team possesses over 100 years of combined experience in mission-critical visual software and hardware system development.
Most importantly, our entire organization is focused on providing a unique level of customer care and support. Resonant was founded by clinicians with a deep understanding of, and respect for the needs, expectations and requirements of cancer centers. Our business development and customer support teams have cumulated years of clinical experience in cancer centers, as well as industry experience with established vendors, and all are highly motivated to support customers.